首页> 外文会议>Laser and Noncoherent Ocular Effects: Epidemiology, Prevention, and Treatment >Morphologic evaluations of Q-switched Nd:YAG laser injury of human retina
【24h】

Morphologic evaluations of Q-switched Nd:YAG laser injury of human retina

机译:调Q Nd:YAG激光对人视网膜的形态学评价

获取原文

摘要

Abstract: Depiction of the cellular and immune responses in the human model is critical to design rational therapies preventing/limiting cellular destruction and ultimately functional visual loss following acute laser injuries. We report the light and electron microscopy histologic findings in a controlled ocular human laser exposure. Following informed consent, the normal eye of a patient scheduled to undergo exenteration for invasive carcinoma of the orbit was exposed to both continuous wave and Q-switched lasers. Four hours prior to exenteration, argon G lesions were placed in the superior/temporal quadrant and Nd:YAG lesions were placed in the inferior/temporal quadrant. After enucleation, the retina was prepared for routine light and transmission electron microscopy. Histology of the argon G lesions showed primarily photoreceptor and RPE photocoagulation damage. Neutrophil adhesion was limited within the choroid and no neutrophils were observed in the subretinal space. In contrast, the 4 hr Nd:YAG lesions showed extensive retinal disruption, hemorrhage within subretinal and intraretinal spaces, neutrophil accumulation in the retina, and an extensive neutrophil chemotaxic and emigration response in the choroid. Severe laser injuries elicit a significant neutrophil response by 4 hr, suggesting that neutrophils should be an early stage therapeutic target. !4
机译:摘要:描述人类模型中细胞和免疫应答的描述对于设计理性疗法预防/限制细胞破坏并最终急性激光损伤后的功能性视觉损失至关重要。我们在受控眼部人类激光曝光中报道了光和电子显微镜的组织学发现。在知情同意之后,预定患者的正常眼睛被暴露于连续波和Q切换激光器的侵入性癌侵入性癌的Exteration。在过滤前4小时,将氩气损伤置于上级/颞象象限和Nd:YAG病变中置于劣质/颞象象限中。在enucleation之后,将视网膜制备用于常规光和透射电子显微镜。氩气损伤的组织学主要显示出光感受器和RPE光凝损伤。中性粒细胞粘附在脉络膜内有限,在脉络膜空间中没有观察到中性粒细胞。相比之下,4小时Nd:YAG病变显示出广泛的视网膜破坏,子血管内空间内的出血,视网膜中的中性粒细胞积累,以及脉络膜中的广泛中性粒细胞趋化性和移除响应。严重的激光损伤引发了4小时的显着中性粒细胞反应,表明中性粒细胞应该是早期治疗目标。 !4

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号